Safety Considerations for Fibromyalgia Patients on Semaglutide Fibromyalgia patients considering semaglutide should discuss potential side effects with their provider, particularly nausea and gastrointestinal changes, which can intersect with fibromyalgia-related digestive sensitivity in some individuals
7.2 Integration With Lipid Management Statins, ezetimibe, PCSK9 inhibitors, inclisiran, and bempedoic acid remain foundational therapy for atherogenic-lipoprotein reduction
Comprehensive Review of Pregnancy Safety Evidence To address this gap, the research team carried out a systematic review and meta-analysis following PRISMA 2020 guidelines, with the study protocol registered on PROSPERO beforehand
Medical practitioners typically recommend semaglutide to adults who meet one of the following criteria: A body mass index (BMI) of 30 or higher (classified as obese) A BMI of 27 or higher with at least one weight-related health condition, such as hypertension or Type 2 diabetes Its important to note that semaglutide isnt a quick fix or a cosmetic solution
